The GH/IGF-1 system in critical illness

Short Title:
Model System:
Reference Type:
Journal Article
Accession No.:
Best Pract Res Clin Endocrinol Metab
Year, Volume, Issue, Page(s):
2011, vol. 25, issue 5, pp 759-67
Publication Website:
The Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) axis plays a pivotal role in critical illness, with a derangement leading to profound changes in metabolism. Protein wasting with skeletal muscle loss, delayed wound healing, and impaired recovery of organ systems are some of the most feared consequences. The use of human recombinant Growth Hormone (rhGH) and Insulin-like Growth Factor-1 (IGF-1) - alone and in combination - has been studied extensively in preclinical and clinical trials. This article reviews the current knowlegde and clinical practice of the use of rhGh and IGF-1 in critically ill patients, with a special focus on the trauma and burns patient population.
Elijah IE.; Branski L.K.; Finnerty C.C.; Herndon D.N.
Author Address(es):

Some items may be available for document delivery from the National Rehabilitation Information Center. Make a note of the title and any accession number and contact NARIC at 800-346-2742 to request a copy. There is a charge for document delivery from the NARIC collection.